Cempra Inc (NASDAQ:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the treatment of bacterial infectious diseases, today …
Analyst Ritu Baral of Cowen & Co was out today with research notes on drug makers Sarepta Therapeutics Inc (NASDAQ:SRPT) and Cempra Inc (NASDAQ:CEMP), discussing the FDA …
Cempra Inc (NASDAQ:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the treatment of bacterial infectious diseases, …
Analysts weigh in on biotechnology stocks Juno Therapeutics Inc (NASDAQ:JUNO) and Cempra Inc (NASDAQ:CEMP). Both are bullish as Juno Therapeutics receives $50 million from collaboration partner Celgene, …
Cempra Inc (NASDAQ:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics in the face of rising antibiotic resistant bacterial infections, today reported financial …
Cempra, Inc. (NASDAQ:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics in the face of rising antibiotic resistant bacterial infections, today announced the publication …
Cempra Inc (NASDAQ:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the treatment of bacterial infectious diseases, and …
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) shares closed down about 13% after the company announced a proposed public offering of its common stock yesterday.
